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Fractional Flow
Reserve Estimation
by Coronary Computed
Tomography Angiography
We read with great interest the paper about the DISCOVER-
FLOW (Diagnosis of Ischemia-Causing Stenoses Obtained Via
Noninvasive Fractional Flow Reserve) study, which compared frac-
tional flow reserve (FFR) derived from coronary computed tomogra-
phy angiography (CTA) with invasive FFR measurements (1). CTA
is a reliable test to rule out coronary artery disease based on its high
sensitivity and negative predictive value compared with conventional
angiography as the reference (2). Considering the importance of
nvasive FFR as part of conventional coronary angiography for
ubsequent revascularization decisions (3), it would be game-changing
f a reliable estimation of FFR could be performed noninvasively (4).
The DISCOVER-FLOW study is an important step in this
irection. We would like to discuss 2 issues related to the study
esign and statistics.
1. Patients with an at least 50% diameter stenosis determined by
he clinical site on CTA were studied using invasive FFR, which
erved as the reference in the study, but was done as clinically
ndicated. Thus, the final cohort of vessels that had invasive FFR
easurements represents a subgroup that may be biased by the
ocal CTA reading and a higher prevalence. This results in an
verestimation of sensitivity and an underestimation of specificity.
his can be seen from a different version of the Bayes formula
eeded to calculate sensitivity from predictive values: sensitivity 
PV · T/(PPV · T (1NPV) · T), where T and T are the
proportion of test positives and negatives in the study sample and
PPV and NPV are the positive and negative predictive values.
The proportion of test negatives, T is underestimated, if T is
calculated in the sample of verified subjects or vessels only. A very
conservative estimate is to assume 3 vessels per person (i.e., 309
vessels overall). According to Koo et al. (1) 114 vessels were positive
(53 true positive, 61 false positive) on CTA. Thus, we assume 195
negative vessels by CTA from which only 45 were assessed by the
reference standard FFR. If we further assume that the observed
Corrected Diagnostic Performance CharacteristicsTable 1 Corrected Diagnostic Performance Characteristics
Listed Diagnostic
Performance of CTA (1)
Corrected Diagnostic
Performance of CTA
Sensitivity, % 91.4 71.0
Specificity, % 39.6 74.0
Negative predictive
value, %
88.9 97.4CTA  computed tomography angiography.negative predictive value is the true one, we can obtain corrected
diagnostic performance estimates (Table 1). It is likely that the same
holds true for computed tomography FFR. However, it is difficult
to assess this without the correlation structure of both index tests
within truly diseased and truly unaffected vessels. If both tests are
conditionally independent (i.e., independent within the true pos-
itives and the true negatives), the naive estimates of sensitivity and
specificity are unbiased.
2. The limits of agreement between FFR and computed
tomography FFR resulting from a regression of absolute differences
according to Altman (5) suggest that these are not constant but
increase linearly with smaller FFR results (r2 linear model 0.335,
r2 quadratic model  0.340, r2 cubic model  0.340) (Fig. 1). In
ther words, the more positive (lower) the FFR results become, the
arger are the limits of agreement (95% confidence intervals).
These additions may be important when appraising the impres-
ive DISCOVER-FLOW study results.
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Figure 1 Bland-Altman Analysis of FFR and CT-FFR
The difference between the upper and lower limits of agreement for the com-
parison of fractional flow reserve (FFR) and computed tomography fractional
flow reserve (CT-FFR) are not constant but increase linearly with smaller FFR
results (5). Thus, the agreement between FFR and CT-FFR becomes less accu-
rate with positive (0.8) measurements.doi:10.1016/j.jacc.2011.12.031
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Reply
We thank Dr. Martus and colleagues for their interest in
DISCOVER-FLOW, a prospective multicenter study that dem-
onstrates the high diagnostic performance of fractional flow reserve
derived from typically acquired coronary computed tomography
angiograms (FFRCT) (1). We share their enthusiasm for this
“game-changing” technology that enables noninvasive computa-
tion of coronary flow and pressure for the determination of
lesion-specific ischemia.
Dr. Martus and colleagues suggest that in the DISCOVER-
FLOW study, the performance of CT stenosis severity and
FFRCT against an invasive FFR reference standard may have been
affected by workup bias because the decision to perform FFR was
based on clinical indications after identification of 50% stenosis
by CT. Dr. Martus and colleagues propose a statistical correction
to account for individuals with no or mild stenoses by CT who
were not subjected to FFR. This approach is certainly suitable to
reduce the relative contribution of referral bias when performance
measures of CT stenosis are judged against invasive angiography
provoked by CT findings because the ability to identify or exclude
a stenosis applies equally and universally to all patients undergoing
CT. However, this approach is inappropriate for assessing the
performance of FFRCT because the population for whom FFRCT
would be expected to be applied are those with CT-identified
stenoses that could both cause ischemia and be eligible for
revascularization. In this regard, a 50% stenosis threshold invessels 2 mm in diameter was chosen as an appropriate cutoff,
given the low rates of ischemia for lesions with50% stenosis and,
more importantly, the widely accepted reluctance to revascularize
nonobstructive coronary lesions. Even more fundamental, subject-
ing individuals who lacked any CT or invasive evidence of
significant disease to FFR would have been both logistically
difficult as well as questionably ethical.
Dr. Martus and colleagues note that the limits of agreement
between FFRCT and invasive FFR increase in a manner that is
inversely proportional to the FFR values. They provide a figure
that illustrates a very shallow negative slope of a regression line
superimposed on a Bland-Altman plot that visually begins to
diverge from the average of FFR and FFRCT at values 0.75.
here are numerous technological explanations for this, which are
he subject of a review that we are preparing, but this negligible
ivergence has limited bearing on the clinical application of
FRCT. Robust standards for ischemia based on FFR have been
firmly established at values 0.80 in randomized trials, and all
values 0.80 should thus be considered ischemia causing (2). To
date, the relative impact of lesions with different values of 0.80
remains unexplored. Further, values 0.80, where the limits of
agreement of FFRCT and FFR are very close, are widely accepted
as pathognomonic for those that are unquestionably not ischemia
causing and for which revascularization can and should be safely
avoided. The DISCOVER-FLOW study results support the high
diagnostic performance of FFRCT for both of these groups.
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